ArticlePsychoneuroendocrinology2025
Early life stress, psychiatric conditions, and mitochondrial DNA copy number (mtDNAcn) in medically healthy young adults.
Article in Psychoneuroendocrinology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Adaptation of mtDNA content to endurance training, a cross-sectional study and an endurance training intervention.European journal of applied physiology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
backgroundEarly life stress (ELS) is a well-established risk factor for psychiatric conditions across the lifespan. A growing body of evidence indicates that alterations to mitochondrial DNA may result from chronic activation of physiological stress responses in ELS and may be associated with psychiatric outcomes. Several studies have found relationships between a number of psychiatric conditions and mtDNA copy number (mtDNAcn), with emerging evidence for a role of early life stress in these associations. This study examined mtDNAcn in physically healthy young adults with and without ELS and a broad range of psychiatric conditions.
methodsParticipants (N = 181; 69.1 % female) included those with ELS and psychiatric conditions (n = 59; ELS+Psych), ELS and no psychiatric conditions (n = 49; ELS-Psych), and with neither ELS nor psychiatric conditions (n = 73; Controls). Standardized interviews and self-reports assessed demographics, stress, and mental health. DNA from PBMCs was used as input for ultra-low coverage whole genome sequencing (ULC-WGS); mtDNAcn was quantified using the fastMitoCalc tool. ANOVAs were used to examine group differences and negative binomial regression models assessed ELS, psychopathology and mtDNAcn relationships with covariates age and sex.
resultsELS+Psych individuals had significantly greater mtDNAcn compared to Control participants (p < .05), even after adjusting for relevant covariates. There was no difference between ELS-Psych individuals and Control participants.
conclusionsIncreased rates of mtDNAcn among individuals with ELS+Psych, but not among those with ELS-Psych, compared to Controls indicates that observable effects of ELS may only occur in the presence of psychiatric symptomatology. Findings and future directions are discussed.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.